Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials.
作者： Jelena Savović , Hayley E. Jones , Douglas G. Altman , Ross J. Harris , Peter Jüni
DOI: 10.7326/0003-4819-157-6-201209180-00537
关键词: Clinical trial 、 Systematic review 、 Bayes' theorem 、 Demography 、 Observational study 、 Credible interval 、 Odds ratio 、 Research design 、 Medicine 、 Randomized controlled trial
摘要: … on average intervention effect estimates and between-trial, … We found weak evidence that intervention effect estimates are … We found no evidence that intervention effect estimates are …
core.ac.uk
bristol.ac.uk
sci-hub.se 参考文章(38)
Peta M Forder, Val J Gebski, Anthony C Keech, Allocation concealment and blinding: when ignorance is bliss. The Medical Journal of Australia. ,vol. 182, pp. 87- 89 ,(2005) , 10.5694/J.1326-5377.2005.TB06584.X
M Egger, P Jüni, C Bartlett, F Holenstein, J Sterne, How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. Health Technology Assessment. ,vol. 7, pp. 1- 76 ,(2003) , 10.3310/HTA7010
David J. Lunn, Andrew Thomas, Nicky Best, David Spiegelhalter, WinBUGS – A Bayesian modelling framework: Concepts, structure, and extensibility Statistics and Computing. ,vol. 10, pp. 325- 337 ,(2000) , 10.1023/A:1008929526011
Jørgen Vestbo, Julie Anne Anderson, Peter Mark Anthony Calverley, Bartolomé Celli, Gary Thomas Ferguson, Christine Jenkins, Julie Carol Yates, Paul Wyatt Jones, Bias due to withdrawal in long-term randomised trials in COPD: evidence from the TORCH study. Clinical Respiratory Journal. ,vol. 5, pp. 44- 49 ,(2011) , 10.1111/J.1752-699X.2010.00198.X
Karin Huwiler-Müntener, Peter Jüni, Christoph Junker, Matthias Egger, Quality of reporting of randomized trials as a measure of methodologic quality. JAMA. ,vol. 287, pp. 2801- 2804 ,(2002) , 10.1001/JAMA.287.21.2801
Catherine L Hill, Michael P LaValley, David T Felson, Discrepancy between published report and actual conduct of randomized clinical trials. Journal of Clinical Epidemiology. ,vol. 55, pp. 783- 786 ,(2002) , 10.1016/S0895-4356(02)00440-7
Asbjørn Hróbjartsson, Julie Pildal, An-Wen Chan, Mette T. Haahr, Douglas G. Altman, Peter C. Gøtzsche, Reporting on blinding in trial protocols and corresponding publications was often inadequate but rarely contradictory Journal of Clinical Epidemiology. ,vol. 62, pp. 967- 973 ,(2009) , 10.1016/J.JCLINEPI.2009.04.003
Kenneth F Schulz, Iain Chalmers, Richard J Hayes, Douglas G Altman, Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials JAMA: The Journal of the American Medical Association. ,vol. 273, pp. 408- 412 ,(1995) , 10.1001/JAMA.273.5.408
Eveline Nüesch, Stephan Reichenbach, Sven Trelle, Anne W. S. Rutjes, Katharina Liewald, Rebekka Sterchi, Douglas G. Altman, Peter Jüni, The importance of allocation concealment and patient blinding in osteoarthritis trials: a meta-epidemiologic study. Arthritis & Rheumatism. ,vol. 61, pp. 1633- 1641 ,(2009) , 10.1002/ART.24894
David Moher, Sally Hopewell, Kenneth F Schulz, Victor Montori, Peter C Gøtzsche, Philip J Devereaux, Diana Elbourne, Matthias Egger, Douglas G Altman, None, CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials BMJ. ,vol. 340, pp. 28- 55 ,(2010) , 10.1136/BMJ.C869